News

BRAINBox Solutions Announces Appointment of Richard H. Noel as Chief Product and Commercial Officer

BRAINBox Solutions today announced the appointment of Richard H. Noel to the newly created position of Chief Product and Commercial Officer. Richard brings more than 10 years of experience in molecular and point-of-care diagnostics, at Roche Diagnostics, LumiraDx, and bioMérieux.

“Richard, whose expertise spans market analytics, global product management, and senior commercial leadership, has established a strong track record at leading diagnostics companies,” said Donna Edmonds, BRAINBox Solutions CEO. “He is well positioned to lead the commercial planning and launch for our BRAINBox TBI concussion diagnostic/prognostic tests.”

“BRAINBox has a unique opportunity to change the standard of care for concussion management with its BRAINBox TBI tests, the first objective tests for the diagnosis and risk of long-term complications,” said Mr. Noel. “The company has built an outstanding foundation with product and clinical development and strong relationships with key thought leaders in neurology and emergency medicine. I look forward to working with the team to bring these promising tests to clinicians and patients.”

Mr. Noel began his career in diagnostics at bioMérieux as a market analyst in the BioFire diagnostics unit, rising to Global Product Manager, where he served as global product leader for numerous syndromic molecular diagnostic panels, analyzers and software solutions. At Lumira, he served as Senior Director of Marketing, North America, where he led the marketing strategy and launch of the company’s novel SARS-CoV-2 Ag test during the Covid pandemic. He spearheaded the marketing strategy for the company’s North American point-of-care business, launching and scaling it from $0 to $440 million in revenue within 24 months. Following LumiraDx’s acquisition by Roche Diagnostics in 2024, he guided the full integration of the LumiraDx commercial business and roadmap.

Before entering the diagnostics industry, Mr. Noel taught honors physics, chemistry, and cognitive neuroscience. He holds a Master’s degree in Business and Biotechnology from the University of Utah and a Bachelor’s degree in Psychology from UC San Diego.

Read more here.

Recent News

06/23/2026

Scout Space raises Series A second close from VTC Ventures, Long Knife, and 100KM

Scout Space, a space domain awareness sensor and software provider, has announced the second close of its Series A financing, adding VTC Ventures, Long Knife and 100KM to its investor syndicate. The initial close occurred in May 2026, led by Washington Harbour Partners. The funding will accelerate deployment of Scout’s in-orbit sensor network, support upcoming

06/22/2026

Icarus Medical Secures $7.2 Million Series A to Accelerate Growth and Innovation

Icarus Medical, a Charlottesville-based med-tech company focused on advancing orthopedic bracing technology, today announced the successful close of its Series A financing round. Originally targeting $5 million, the round closed oversubscribed at $7.2 million, reflecting strong investor confidence in the company’s technology platform, market momentum, and long-term vision. Orthopedic bracing company Icarus Medical closes oversubscribed

06/16/2026

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to